Skip to content

Autologous Transfusion In Surgery: a randomised clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85756518
Enrollment
Unknown
Registered
2004-01-23
Start date
1997-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases: Peripheral arterial disease Circulatory System Peripheral arterial disease

Interventions

1. Autologous transfusion: acute normovolaemic haemodilution and intragerative cell salvage 2. Homologous transfusion: homologous blood if required

Sponsors

NHS R&D Regional Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients undergoing elective surgery for either occlusive or aneurysmal arterial disease will be asked to give written informed consent: 1. Both men and women aged 30-85 2. Considered fit for aortic surgery without any of the exclusion criteria 3. Pre-operative haemoglobin >11 g/dl and platelet count >150 x 10^9/1 4. Adequate cardiac and pulmonary function clinically

Exclusion criteria

Exclusion criteria: Any patient unfit for aortic surgery, unable for any reason to receive either autologous or standard transfusion therapy, or undergoing emergency surgery for suspected rupture of an aneurysm.

Design outcomes

Primary

MeasureTime frame
Blood transfusion requirements, haematological and haemostatic parameter, post-operative infection, morbidity and hospital stay, economic analysis

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026